| Primary |
| Acute Promyelocytic Leukaemia |
65.9% |
| Acute Myeloid Leukaemia |
8.6% |
| Acne |
6.4% |
| Drug Use For Unknown Indication |
3.4% |
| Prophylaxis |
2.5% |
| Product Used For Unknown Indication |
1.6% |
| Skin Hyperpigmentation |
1.6% |
| Antifungal Prophylaxis |
1.4% |
| Myelodysplastic Syndrome |
1.4% |
| Psoriasis |
1.4% |
| Hypertension |
0.9% |
| Alopecia Areata |
0.7% |
| Drug Exposure During Pregnancy |
0.7% |
| Refractory Anaemia |
0.7% |
| Skin Wrinkling |
0.7% |
| Antibiotic Prophylaxis |
0.5% |
| Antibiotic Therapy |
0.5% |
| Chloasma |
0.5% |
| Clostridial Infection |
0.5% |
| Febrile Neutropenia |
0.5% |
|
| Haemorrhage Intracranial |
13.0% |
| Retinoic Acid Syndrome |
12.5% |
| Sepsis |
12.0% |
| Pulmonary Haemorrhage |
7.3% |
| Cytogenetic Abnormality |
6.3% |
| Pneumonia |
5.7% |
| Myelodysplastic Syndrome |
5.2% |
| Acute Myeloid Leukaemia |
4.2% |
| Death |
4.2% |
| Thrombocytopenia |
4.2% |
| Bacterial Sepsis |
3.6% |
| Malignant Neoplasm Progression |
3.6% |
| Multi-organ Failure |
3.6% |
| Off Label Use |
2.6% |
| Benign Intracranial Hypertension |
2.1% |
| Haemorrhage |
2.1% |
| Neuropathy Peripheral |
2.1% |
| Pyrexia |
2.1% |
| Thermal Burn |
2.1% |
| Hepatic Function Abnormal |
1.6% |
|
| Secondary |
| Acute Promyelocytic Leukaemia |
42.6% |
| Acute Myeloid Leukaemia |
27.9% |
| Myelodysplastic Syndrome |
7.0% |
| Neuroblastoma |
5.8% |
| Drug Use For Unknown Indication |
2.4% |
| Acne |
1.9% |
| Product Used For Unknown Indication |
1.6% |
| Antibiotic Therapy |
1.3% |
| Psoriasis |
1.1% |
| Antifungal Prophylaxis |
1.0% |
| Alopecia |
0.9% |
| Cellulitis |
0.9% |
| Chemotherapy |
0.9% |
| Dermatitis |
0.9% |
| Hypertension |
0.7% |
| Pyrexia |
0.7% |
| Febrile Neutropenia |
0.6% |
| Pneumonia |
0.6% |
| Prophylaxis |
0.6% |
| Erythroleukaemia |
0.5% |
|
| Acute Myeloid Leukaemia |
15.4% |
| Pneumonia |
8.3% |
| Sepsis |
8.3% |
| Chronic Myelomonocytic Leukaemia |
7.7% |
| Hyperbilirubinaemia |
7.1% |
| Multi-organ Failure |
6.4% |
| Myelodysplastic Syndrome |
5.8% |
| Pyrexia |
5.1% |
| Bacterial Sepsis |
4.5% |
| Febrile Neutropenia |
4.5% |
| Pregnancy |
3.2% |
| Retinoic Acid Syndrome |
3.2% |
| Alanine Aminotransferase Increased |
2.6% |
| Cytogenetic Abnormality |
2.6% |
| Death |
2.6% |
| Malignant Neoplasm Progression |
2.6% |
| Pain |
2.6% |
| Pulmonary Embolism |
2.6% |
| Renal Failure Acute |
2.6% |
| Venoocclusive Liver Disease |
2.6% |
|
| Concomitant |
| Acne |
17.4% |
| Product Used For Unknown Indication |
13.2% |
| Acute Myeloid Leukaemia |
11.3% |
| Acute Promyelocytic Leukaemia |
9.5% |
| Contraception |
6.4% |
| Prophylaxis |
6.1% |
| Hypertension |
5.1% |
| Drug Use For Unknown Indication |
4.4% |
| Depression |
3.5% |
| Osteoporosis |
3.1% |
| Psoriasis |
2.8% |
| Pyrexia |
2.7% |
| Asthma |
2.6% |
| Rheumatoid Arthritis |
2.0% |
| Infection Prophylaxis |
1.8% |
| Prophylaxis Of Nausea And Vomiting |
1.8% |
| Anxiety |
1.7% |
| Pain |
1.6% |
| Abdominal Pain |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
|
| Vomiting |
9.9% |
| Deep Vein Thrombosis |
7.4% |
| Weight Increased |
7.4% |
| Pain |
6.6% |
| Gallbladder Disorder |
5.8% |
| Tooth Extraction |
5.8% |
| Drug Ineffective |
5.0% |
| Nausea |
5.0% |
| Pulmonary Embolism |
5.0% |
| Vascular Graft Occlusion |
5.0% |
| Ventricular Tachycardia |
5.0% |
| Vitreous Haemorrhage |
5.0% |
| Syncope |
4.1% |
| Viral Infection |
4.1% |
| Renal Failure Acute |
3.3% |
| Sepsis |
3.3% |
| Thrombophlebitis Superficial |
3.3% |
| Vision Blurred |
3.3% |
| Weight Decreased |
3.3% |
| Abdominal Pain |
2.5% |
|
| Interacting |
| Acute Promyelocytic Leukaemia |
59.7% |
| Antifungal Prophylaxis |
14.5% |
| Drug Use For Unknown Indication |
6.5% |
| Prophylaxis |
4.8% |
| Staphylococcal Infection |
4.8% |
| Anaemia |
3.2% |
| Febrile Neutropenia |
3.2% |
| Thrombocytopenia |
3.2% |
|
| Retinoic Acid Syndrome |
20.8% |
| Renal Failure Acute |
16.7% |
| Benign Intracranial Hypertension |
8.3% |
| Multi-organ Failure |
8.3% |
| Renal Disorder |
8.3% |
| Renal Impairment |
8.3% |
| Vomiting |
8.3% |
| Abdominal Distension |
4.2% |
| Blood Bilirubin Increased |
4.2% |
| Metabolic Acidosis |
4.2% |
| Pneumonia Klebsiella |
4.2% |
| Septic Shock |
4.2% |
|
